@hmac8

Senior editor and writer @biospace|The Weekly podcast guest| animal advocate|baseball nut #biopharma #healthcare #raredisease #biotech

 London, ON
Joined July 2009
  • Tweets25
  • Following50
  • Followers50
The @Sarepta saga brought to light the veritable communications disaster that has confused the #Duchennemusculardystrophy community and exposed leaks within the #FDA. And it didn’t just start with Sarepta and #Elevidys. My latest for @BioSpace biospace.com/fda/unprecedent…

'Unprecedented' FDA Leaks Sow Confusion for Patients, Sarepta and Capricor

Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy families have turned to the news for answers. Meanwhile, the FDA insists it...

biospace.com
2
5
1,168
Heather McKenzie retweeted
Richard W. Painter
@RWPUSA2 May 2025
As I told Heather McKenzie here: “There’s objective truth in science, and the extreme left and extreme right have always wanted to deny objective truth....most of the politicization of science has been on the far right in the United States.” biospace.com/policy/biomedic…

Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths

As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.

biospace.com
2
7
19
3,499
🧠 HUGE NEWS - $AZN out of Neuro!!!! Big loss for patients….disappointing “CNS really is probably better managed by other companies that have a focus on that.” “We have closed our neuro programs and identified partners for some of them,” noted Sharon Barr, executive vice president of BioPharmaceuticals R&D at AstraZeneca. biospace.com/business/astraz…
7
7
2
55
10,060
#biopharma conference season is in full swing, and our very own @JefAkst and @Slabodkin will be at hashtag#ASGCT24 in Baltimore next week. biospace.com/article/biospac…

BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy

Follow News Editor Greg Slabodkin and Managing Editor Jef Akst as they travel with some 8,000 others for discussions of cell and gene therapy advances, challenges, regulations and more.

biospace.com
177
Join @Slabodkin, Tyler Patchen and I as we discuss @sanofi #layoffs, #GLP1s, a new boxed warning on CAR-T therapies, and as an added bonus, the proper way to pronounce "Sanofi". @JefAkst biospace.com/article/sanofi-…

Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player

While Sanofi restructures and parts with employees from U.S. and Belgian sites, a new company in the GLP-1 space emerges from stealth.

biospace.com
182
Early data indicate stem cell therapies could help people with Parkinson's disease generate dopamine again. Wouldn't that be something? #Parkinsons @biospace biospace.com/article/early-d…

Early Data Indicate Cell Therapies Could ‘Reset the Clock’ in Parkinson’s

A one-time treatment for Parkinson’s disease could be a ‘market changer,’ experts told BioSpace, adding that cell therapies could limit the adverse effects seen with current drugs.

biospace.com
1
1
286
One #MASH therapy past the gate. “An important first.” But can we improve on it? biospace.com/article/5-promi…

5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra

Metabolic dysfunction-associated steatohepatitis experts welcomed Madrigal’s Rezdiffra as an “important first," but there are more mid- to late-stage therapies showing promising results.

biospace.com
45
Heather McKenzie retweeted
BioSpace@biospace15 Apr 2024
Metabolic dysfunction-associated steatohepatitis experts welcomed #Madrigal’s Rezdiffra as an “important first," but there are more mid- to late-stage therapies showing promising results. Writes @biospace's @hmac8. #pharma #biospace hubs.li/Q02sSVR20

5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra

Metabolic dysfunction-associated steatohepatitis experts welcomed Madrigal’s Rezdiffra as an “important first," but there are more mid- to late-stage therapies showing promising results.

biospace.com
1
1
395
Bernie Zipprich makes a very good point—backed up by an intriguing recent NIH study. @biospace #ALS biospace.com/article/opinion…

Opinion: ALS Is Not a Singular Disease. Stop Treating It Like One

Imagine testing a really good drug for HER2+ breast cancer in someone with liver cancer. Would it be any surprise when that drug fails?

biospace.com
1
2
1
2
942
Just when it seems like #geneediting can't get any hotter—what about editing parts of the genetic code beyond the DNA itself? @EpicBiotech #Innovation @biospace biospace.com/article/epigene…

Epigenetic Editing Explodes on the Heels of Gene Editing Success

Ubiquitous potential, possible safety advantages and the recent growth of cell and gene therapy are driving investment in a different type of genetic editing.

biospace.com
1
1
296
Heather McKenzie retweeted
BioSpace@biospace25 Mar 2024
The recent @US_FDA decision will likely mean more #Medicare patients gain access to the blockbuster weight loss drug, experts say. Meanwhile, results continue to roll in for GLP-1 agonists for conditions beyond diabetes and obesity. #glp1 #pharma #biospace hubs.li/Q02qyj8p0

Wegovy Cardiovascular Approval Furthers March into New Indications

The recent FDA decision will likely mean more Medicare patients gain access to the blockbuster weight loss drug, experts say. Meanwhile, results continue to roll in for GLP-1 agonists for conditions...

biospace.com
2
3
420
A very deserving group of patients got a much-needed new treatment option yesterday as the #FDA approved the third #Duchenne muscular dystrophy treatment in nine months. @biospace @ITALFARMACO biospace.com/article/fda-app…

FDA Approves Third Duchenne Muscular Dystrophy Treatment in Nine Months

Duvyzat, which will be sold in the U.S. by ITF Therapeutics, joins a growing market that includes recently approved gene therapy Elevidys and corticosteroid Agamree.

biospace.com
21
A very deserving group of patients got a much-needed new treatment option yesterday as the #FDA approved the third #Duchenne muscular dystrophy treatment in nine months. @biospace @CureDuchenne @ITALFARMACO
2
1
324
Nice insights from Chantal Dresner and the BioSpace marketing team! Nice to see an "incremental improvement" in the #gendergap, but faster progress is sorely needed. biospace.com/article/report-…

Report: 2024 U.S. Life Sciences Salary Trends

BioSpace's 2024 Salary Report explores the average salaries and salary trends of life sciences professionals.

biospace.com
1
346
In one of this year's most anticipated #FDA decisions, the agency approved the first-ever therapy for metabolic dysfunction-associated steatohepatitis. Congratulations to @Madrigal Pharmaceuticals! @BioSpace @FDA #fdaapproval biospace.com/article/fda-app…

FDA Approves Madrigal’s Rezdiffra as First MASH Therapy

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) is the first-ever approved therapy for metabolic dysfunction-associated steatohepatitis—a decision experts say could signal a sea change in treatment...

biospace.com
1
1
337
Centers for Disease Control and Prevention: Push CDC to consider Long COVID a chronic illness - Sign the Petition! chng.it/9yYj6q2d via @CdnChange

Sign the Petition

Petition CDC to consider Long COVID as a chronic illness

change.org
Heather McKenzie retweeted
Biden2020@brobiden202015 Nov 2016
Brobama and Broden! #BidenMemes #Biden #BidenAndObama #bidenobamamemes #joebiden #Joebama #Biden2020 #brobiden #brobama #Veep
1
Gordon honors Fernandez, hits a home run in surreal scene sbnation.com/lookit/2016/9/2… via @
Animal Lovers: PLEASE Sign this to save precious lives! Petition update - Reaching 35K signatures! change.org/p/8180177/u/17892… via @CdnChange
Hello Ben, I'd like to invite you to speak on Supplier Sustainability at an executive event, October in Atlanta. Please send e-mail for more
Load more